EuroPCR '25 Pulmonary Embolism banner

ACCESS EUROPCR 2025 REPLAY

Master Pulmonary
Embolism.
Save lives. 

Discover a simple low-profile solution to the Pulmonary Embolism problem: EKOSTM    

Watch the EuroPCR 2025 session on Pulmonary Embolism (PE) and stay informed about the latest insights in PE care.

Timely, effective treatment of Pulmonary Embolism is critical to reducing complications and saving lives. In this expert-led session, you will hear from leading voices in the field as they explore current challenges, emerging strategies, and innovations in PE management..

Session details

Speakers

 Andrew Sharp Andrew Sharp, MD
Robert  Ariëns Robert Ariens, MD
Stavros Konstantinides​ Stavros Konstantinides, MD
Jakub  Stepniewski Jakub Stepniewski, MD

  • The effect of ultrasound on clot and clot structure.
  • Insights from the HI-PEITHO study, a state-of-the-art randomised trial.
  • How to apply insights from real cases to build your own treatment strategy and take-home examples.

Short on time? Skip to chapters highlights

1. Panel Overview 0:00
Welcome and session goals. Introduction of panelists.

2. Introduction by Andrew Sharp 0:49
Risk stratification and catheter-directed thrombolysis with EKOS.

3. The impact of ultrasound on clot structure: a dynamic duo. By Robert Ariëns 4:13
Fibrin clot structure and thrombosis-dense clots and effects of the application of ultrasounds to thin fibers.

4. First round of Panel Discussion. 13:33
Questions from the audience and clarifications from the panelists.

5. HI-PEITHO: Is the future of severe PE interventional? By Stavros Konstantinides 19:33
Description of the study; criteria of inclusion and implication of the possible results.

6. Interactive real case study by Jakub Stepniewski 33:00
Description and initial diagnosis. Step-by-step catheter procedural insights.

7. Final Comments 46:13
Takeaways and closing remarks.


"EKOS is capable of providing improvement in right ventricular function and pulmonary perfusion, enables timely reperfusion in appropriately selected patients, delivers low-dose thrombolytic therapy directed to the clot and is a minimally invasive procedure with a low complication rate."
— Jakub Stepniewski on real case studies with EKOS


Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.